000 01352 a2200385 4500
005 20250516203103.0
264 0 _c20150622
008 201506s 0 0 eng d
022 _a1573-2576
024 7 _a10.1007/s10753-014-9864-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSharifov, Oleg F
245 0 0 _aL-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
_h[electronic resource]
260 _bInflammation
_cOct 2014
300 _a1401-12 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAmino Acid Sequence
650 0 4 _aApolipoprotein A-I
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aLipopolysaccharides
_xantagonists & inhibitors
650 0 4 _aMolecular Mimicry
_xdrug effects
650 0 4 _aMolecular Sequence Data
650 0 4 _aNeutrophils
_xdrug effects
650 0 4 _aPeptides
_xgenetics
700 1 _aXu, Xin
700 1 _aGaggar, Amit
700 1 _aTabengwa, Edlue M
700 1 _aWhite, C Roger
700 1 _aPalgunachari, Mayakonda N
700 1 _aAnantharamaiah, G M
700 1 _aGupta, Himanshu
773 0 _tInflammation
_gvol. 37
_gno. 5
_gp. 1401-12
856 4 0 _uhttps://doi.org/10.1007/s10753-014-9864-7
_zAvailable from publisher's website
999 _c23656764
_d23656764